Tag - daiichi-sankyo

 
Menu
Search
 
November 22, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

DAIICHI SANKYO

Keisuke Yoshida, a former Daiichi Sankyo employee, was sentenced to 16 years in prison on Wednesday for murdering his wife with methanol in 2022.
JAPAN / Crime & Legal
Oct 31, 2024
Ex-employee of drugmaker sentenced to 16 years for methanol murder
Tokyo District Court on Wednesday sentenced a former employee of drugmaker Daiichi Sankyo to 16 years in prison for the murder of his wife by methanol poisoning in 2022.
The Tokyo District Court
JAPAN / Crime & Legal
Oct 11, 2024
Ex-Daiichi Sankyo employee faces 18 years for allegedly poisoning wife
The indictment states that Keisuke Yoshida intentionally poisoned his 40-year-old wife, Yoko, by having her ingest methanol at their home in Tokyo.
Hiroyuki Okuzawa, chief operating officer of Daiichi Sankyo, during an interview in Tokyo on Friday
BUSINESS / Companies
Oct 11, 2024
Daiichi Sankyo eyes newer cancer drugs to stave off rivals
The Japanese drugmaker has emerged as a leader in ADC, a type of cancer therapy that targets cancerous cells while sparing the healthy ones.
Daiichi Sankyo is working on the next generation of targeted cancer drugs.
JAPAN / Science & Health
Sep 17, 2024
Daiichi wants to go it alone in search for targeted cancer drugs
Investors are betting on Daiichi’s continued success, with its share price up 122% in the last five years.
Keisuke Yoshida, 42, is accused of killing his wife by poisoning her with methanol at their home in Tokyo’s Ota Ward between Jan. 14 and 15 in 2022.
JAPAN / Crime & Legal
Sep 2, 2024
Ex-employee of Daiichi Sankyo denies poisoning his wife with methanol
Keisuke Yoshida, formerly a senior researcher at the pharmaceutical firm, said he had never thought of killing his wife.
Health minister Keizo Takemi fields questions from reporters in March after a Cabinet meeting to deal with health problems caused by Kobayashi Pharmaceutical's beni kōji red yeast rice supplements.
JAPAN / Science & Health
Aug 14, 2024
Health Minister Keizo Takemi on how to improve Japan's health care system
Digitalization, hiring high-skilled foreign workers and increasing wages are among the steps that Japan could take.
In the past 11 months, health minister Keizo Takemi has been charting his own path, seeking to make Japan's health care policies more global and digitalized.
JAPAN / Science & Health
Aug 14, 2024
Global mindset crucial for reform of Japan's health care, minister says
International strategies and domestic health care reform are inextricably linked, says health minister Keizo Takemi.
Prime Minister Fumio Kishida receives a COVID-19 booster shot in Tokyo on Nov. 11.
JAPAN / Science & Health
Nov 28, 2023
Japan approves first domestically developed COVID-19 XBB vaccine
The XBB-adapted coronavirus vaccine will be available as a booster under the nation’s free COVID-19 vaccination program beginning next week.
Daiichi Sankyo is aiming for at least ¥900 billion of revenue from its oncology business in the fiscal year ending in March 2026.
BUSINESS
Oct 20, 2023
Merck signs $5.5 billion deal with Daiichi for cancer therapy development
Daiichi Sankyo is aiming for at least ¥900 billion of revenue from its oncology business in the fiscal year ending in March 2026.
A health ministry panel has approved the messenger RNA vaccine Daichirona.
JAPAN / Science & Health
Aug 1, 2023
Japan panel endorses first domestically developed COVID vaccine
The shot is based on the original strain of the coronavirus, making it unlikely that it will be used in Japan or elsewhere.
Japan Times
BUSINESS / Companies
Jun 7, 2023
AstraZeneca’s Japan partner to go solo on future cancer drugs
Daiichi Sankyo is expanding its sales and development staff overseas, aiming to boost production capacity so that it can handle its cancer drugs business entirely on its own.
Japan Times
BUSINESS
Jan 13, 2023
Japan's Daiichi Sankyo applies for approval of mRNA COVID vaccine
An approval would give Japan a homegrown mRNA vaccine — a vaccine type that has played a dominant role in the country's COVID-19 inoculation drive to this point.
Japan Times
JAPAN / Science & Health
Nov 15, 2022
Japan's Daiichi Sankyo says mRNA COVID vaccine successful in booster trial
Approval would give Japan a home-grown source for mRNA vaccines, which have made up the bulk of its COVID-19 inoculations to date.
Japan Times
COMMENTARY / World
Jun 8, 2022
The drug that could transform breast cancer treatment
The early success of Enhertu, from AstraZeneca and Daiichi Sankyo, bodes well for an entire class of medicines that may one day replace conventional chemotherapy.
Japan Times
BUSINESS
Dec 27, 2021
Tardy COVID-19 vaccine makers under fire for trials in developing nations
Vaccine developers at the testing phase now are seeking developing countries where vaccination rates remain low and the virus is still active.
Japan Times
BUSINESS / Companies
Sep 6, 2021
Daiichi Sankyo positions its COVID-19 vaccine as a booster in Japan
Daiichi Sankyo is aiming for full regulatory approval by the second half of next year.
Japan Times
JAPAN / Science & Health
Mar 23, 2021
Japanese firms launch domestic clinical trials for COVID-19 vaccines
Even as Daiichi Sankyo and KM Biologics begin work to prove their shots' efficacy and safety, the public is unlikely to have access to them until fiscal 2022 at the earliest.
JAPAN / Science & Health
Aug 31, 2020
Daiichi Sankyo's COVID-19 vaccine candidate selected by Japanese drug discovery body
Daiichi Sankyo Co. said on Monday that its mRNA-based COVID-19 vaccine candidate was selected for inclusion in a drug discovery program by the Japan Agency for Medical Research and Development.
Japan Times
BUSINESS / Companies
Jul 28, 2020
Astra to pay Daiichi up to $6 billion for new cancer drug
AstraZeneca is forging ahead to become a global oncology powerhouse, even as it works on a vaccine for the coronavirus pandemic.
Two of America’s biggest debt holders are dumping Treasurys
The U.S. Treasury building in Washington. Investors in Japan and China sold a pile of U.S. debt in the last quarter, just before the U.S. presidential election.
Ishiba aggravates his own political failures with diplomatic faux pas
Prime Minster Shigeru Ishiba is greeted at the APEC summit in Lima by Canadian Prime Minister Justin Trudeau on Friday. The Japanese leader was criticized for remaining seated while meeting several world leaders at the event.
Japan's 3.31 million visitors in October set monthly record
Kiyomizu Temple in Kyoto in December 2023. Famous autumn leaf colors contributed to increased tourism demand last month from many markets across Asia, Europe and North America, the Japan National Tourism Organization has said.
Japan ranks last in romance satisfaction for second straight year
In a survey of 31 countries, Japan ranked last in terms of those who felt loved, with just 51% of respondents saying so.
Ruling coalition and DPP strike last-minute deal over economic policy
DPP policy chief Makoto Mahaguchi speaks at the party's policy gathering in Tokyo on Wednesday.
Japan, U.K. and Italy discuss inviting more countries to joint fighter project
A new concept model of a next-generation fighter jet to be jointly developed by Japan, Britain and Italy is on display in Farnborough, Hampshire, in July.
Haruki Murakami's 'The City and Its Uncertain Walls' gives deep deja vu
For “The City and Its Uncertain Walls,” translated into English by Philip Gabriel, Haruki Murakami confronts the ghosts who won't leave him alone.
Japanese expats in Asia find community through rugby
The Taiwan Fivewoods celebrate their victory at the 2023 Asian Japanese Rugby Cup in December of last year.
In Fukushima, a weekend of prose, poetry and translation
Aomori-based writer JJ Carter presented on tabletop gaming as creative inspiration for building characters and narratives.
For Dr. Nakamats, aging is just experience in action
Though he didn't win the recent gubernatorial election in Tokyo, the 96-year-old Dr. Nakamats' run was seen as inspirational in Japan's aging society.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?
By Kathryn Wortley

SUSTAINABLE JAPAN

Azabudai Hills, Tokyo’s green new downtown ‘village’
Azabudai Hills, Tokyo’s green new downtown ‘village’

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER